Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ironwood Pharmaceuticals

0.7267
-0.0233-3.11%
Post-market: 0.72670.00000.00%19:44 EDT
Volume:3.33M
Turnover:2.47M
Market Cap:117.59M
PE:131.39
High:0.7801
Open:0.7492
Low:0.7002
Close:0.7500
Loading ...

Millrose Properties Set to Join S&P SmallCap 600

PR Newswire
·
06 Feb

S&P Dow Jones Indices: Millrose Properties to Replace Ironwood Pharmaceuticals in S&P Smallcap 600 Effective Prior to Market Open on Feb 10

THOMSON REUTERS
·
06 Feb

S&P Dow Jones Indices: Following the Spin-off, Lennar Will Remain in the S&P 500

THOMSON REUTERS
·
06 Feb

Sector Update: Health Care Stocks Gain Thursday

MT Newswires Live
·
31 Jan

Top Midday Decliners

MT Newswires Live
·
31 Jan

IRWD Begins Apraglutide NDA Submission, Announces Job Cuts, Stock Falls

Zacks
·
31 Jan

Ironwood Pharmaceuticals Is Maintained at Market Outperform by JMP Securities

Dow Jones
·
30 Jan

Ironwood price target lowered to $7 from $8 at Craig-Hallum

TIPRANKS
·
30 Jan

Ironwood Pharma (IRWD) Gets a Buy from Craig-Hallum

TIPRANKS
·
30 Jan

Ironwood Pharmaceuticals to Slash Half of Workforce, Drop Phase 2 Testing of Drug; Issues 2025 Outlook

MT Newswires Live
·
30 Jan

Ironwood Pharmaceuticals: Strategic Focus on Apraglutide Drives Long-Term Growth Potential and Buy Rating

TIPRANKS
·
30 Jan

BRIEF-Ironwood Pharmaceuticals Inc - Board Approves 50% Workforce Reduction

Reuters
·
30 Jan

Ironwood initiates apraglutide NDA submission

TIPRANKS
·
30 Jan

Ironwood Pharmaceuticals Inc - Expects $20M-$25M Charges From Workforce Reduction

THOMSON REUTERS
·
30 Jan

Ironwood Pharmaceuticals Inc - Promotes Gregory Martini to CFO

THOMSON REUTERS
·
30 Jan

Ironwood Pharmaceuticals Inc - Board Approves 50% Workforce Reduction

THOMSON REUTERS
·
30 Jan

Ironwood Pharmaceuticals Initiates Apraglutide Nda Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future

THOMSON REUTERS
·
30 Jan

Ironwood Pharmaceuticals Inc - Data Shows Increase in Patients Achieving Enteral Autonomy

THOMSON REUTERS
·
30 Jan

Ironwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future

Business Wire
·
30 Jan

Calculating The Fair Value Of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)

Simply Wall St.
·
23 Jan